These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4201618)

  • 41. Reinstitution of gold after gold induced proteinuria.
    Klinkhoff AV; Teufel A
    J Rheumatol; 1997 Jul; 24(7):1277-9. PubMed ID: 9228124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 43. Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients.
    Lundberg MS; Cannon GW; Ward JR
    Arthritis Rheum; 1988 Jul; 31(7):909-13. PubMed ID: 3134898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gold-induced immune complex nephritis in seronegative rheumatoid arthritis.
    Skrifvars BV; Törnroth TS; Tallqvist GN
    Ann Rheum Dis; 1977 Dec; 36(6):549-56. PubMed ID: 145832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New diagnostic standards in rheumatoid arthritis and recent trends in drug therapy].
    Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):334-7. PubMed ID: 2110235
    [No Abstract]   [Full Text] [Related]  

  • 46. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.
    Gerber RC; Paulus HE; Jennrich RI; Lederer M; Bluestone R; Blahd WH; Pearson CM
    J Lab Clin Med; 1974 May; 83(5):778-89. PubMed ID: 4207022
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Light- and electron-microscopical study of a case of gold salt-induced hepatotoxicity.
    Fleischner GM; Morecki R; Hanaichi T; Hayashi H; Quintana N; Sternlieb I
    Hepatology; 1991 Sep; 14(3):422-5. PubMed ID: 1908434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Towards more individualized parenteral gold therapy].
    Kaarela K; Lehtinen K; Luukkainen R
    Duodecim; 1994; 110(11):1046-7. PubMed ID: 7588110
    [No Abstract]   [Full Text] [Related]  

  • 52. Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis.
    Dorwart BB; Gall EP; Schumacher HR; Krauser RE
    Arthritis Rheum; 1978 Jun; 21(5):513-5. PubMed ID: 96841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients.
    Lockie LM; Smith DM
    Semin Arthritis Rheum; 1985 May; 14(4):238-46. PubMed ID: 2934818
    [No Abstract]   [Full Text] [Related]  

  • 54. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind one year clinical trial comparing alclofenac with gold in rheumatoid arthritis.
    Kadir N; Grayson MF; Campbell ED
    Ann Clin Res; 1983; 15(1):4-9. PubMed ID: 6134490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Combined drug therapy in recent-onset rheumatoid arthritis. Evaluation after 1 year of treatment].
    Biasi D; Caramaschi P; Carletto A; Pacor ML; Zeminian S; Bambara LM
    Recenti Prog Med; 1998 Jan; 89(1):14-7. PubMed ID: 9549387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rheumatoid arthritis V: therapy with remission-inducing agents.
    Gaines LM
    Md State Med J; 1982 Sep; 31(9):49-50. PubMed ID: 6815385
    [No Abstract]   [Full Text] [Related]  

  • 58. Oral gold in rheumatoid arthritis.
    Drug Ther Bull; 1988 Sep; 26(18):69-72. PubMed ID: 3139386
    [No Abstract]   [Full Text] [Related]  

  • 59. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
    Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
    Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
    [No Abstract]   [Full Text] [Related]  

  • 60. [The use of low doses of sodium aurothiomalate in the treatment of rheumatoid arthritis. Current trends in basic therapy].
    Bianucci G; Maddali Bongi S; Cencetti A; Curradi C
    Clin Ter; 1996 Dec; 147(12):609-20. PubMed ID: 9296920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.